| |
| |
|
| Insider
Information: |
Raab Michael |
| Relationship: |
|
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,316,051 |
|
|
Indirect Shares
|
25,364 |
|
|
| Direct
Value |
$8,250,856 |
|
|
|
Indirect Value
|
$150,409 |
|
|
| Total
Shares |
1,341,415 |
|
|
| Total
Value |
$8,401,264 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
10
|
|
Stock
price went up :
|
1
|
6
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.5
|
| Percentage
Gain/Loss : |
 276.6%
|
415.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
President & CEO, Direc... |
2024-09-11 |
1,220,608 |
2024-09-11 |
25,364 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
|
2024-06-06 |
95,443 |
2015-06-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-04-29 |
4 |
OE |
$0.99 |
$29,700 |
D/D |
30,000 |
1,340,933 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-05-14 |
4 |
AS |
$7.99 |
$23,970 |
D/D |
(3,000) |
1,307,933 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-05-21 |
4 |
S |
$7.81 |
$245,922 |
D/D |
(31,484) |
1,277,773 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-05-29 |
4 |
AS |
$6.72 |
$50,390 |
D/D |
(7,500) |
1,270,273 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-06-13 |
4 |
S |
$6.65 |
$232,743 |
D/D |
(35,000) |
1,270,273 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-06-13 |
4 |
OE |
$0.99 |
$34,650 |
D/D |
35,000 |
1,305,273 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-06-28 |
4 |
AS |
$6.59 |
$15,223 |
D/D |
(2,310) |
1,267,963 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-07-15 |
4 |
AS |
$5.97 |
$44,768 |
D/D |
(7,500) |
1,260,463 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-07-29 |
4 |
OE |
$0.99 |
$29,700 |
D/D |
30,000 |
1,290,463 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-07-29 |
4 |
AS |
$5.64 |
$169,314 |
D/D |
(30,000) |
1,260,463 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-08-12 |
4 |
AS |
$5.71 |
$7,018 |
D/D |
(1,229) |
1,259,234 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-08-20 |
4 |
S |
$5.86 |
$188,848 |
D/D |
(32,225) |
1,227,009 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-08-27 |
4 |
AS |
$6.22 |
$46,635 |
D/D |
(7,500) |
1,219,509 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-09-11 |
4 |
OE |
$0.99 |
$34,650 |
D/D |
35,000 |
1,255,608 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-09-11 |
4 |
AS |
$5.61 |
$196,399 |
D/D |
(35,000) |
1,220,608 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2015-06-08 |
4 |
D |
$12.65 |
$113,040 |
D/D |
(8,936) |
0 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,814 |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-10-12 |
4 |
AS |
$14.25 |
$142,534 |
D/D |
(10,000) |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-10-12 |
4 |
OE |
$14.25 |
$142,534 |
D/D |
10,000 |
15,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-01-02 |
4 |
AS |
$15.00 |
$140,490 |
D/D |
(9,366) |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-01-02 |
4 |
OE |
$15.00 |
$140,490 |
D/D |
9,366 |
15,180 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-04-16 |
4 |
OE |
$10.53 |
$52,650 |
D/D |
5,000 |
10,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-04-16 |
4 |
AS |
$14.41 |
$72,058 |
D/D |
(5,000) |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
8,895 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2019-06-03 |
4 |
AS |
$11.16 |
$55,776 |
D/D |
(5,000) |
8,895 |
0 |
- |
|
90 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
